🇺🇸 FDA
Patent

US 10960044

Powder formulation having hypoglycemic and hypolipidemic functions and method for preparing the same

granted A61KA61K2236/00A61K2236/331

Quick answer

US patent 10960044 (Powder formulation having hypoglycemic and hypolipidemic functions and method for preparing the same) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Mar 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2236/00, A61K2236/331, A61K31/733, A61K36/185